Jiong Cai

No ORCID on file · 4 papers in corpus
observational 2024
Scientific reports ·doi:10.1038/s41598-024-51186-5

The objective of this study was retrospectively to analyze the clinical characteristics and 18F-FDG PET/CT findings in Meigs syndrome (MS) patients. A total of 21 patients with MS induced by ovarian stromal tumors and 69 patients with pseud…

review 2022
Frontiers in oncology ·doi:10.3389/fonc.2022.917439

Human epidermal growth factor receptor 2 (HER2) is a highly expressed tumor marker in epithelial ovarian cancer, and its overexpression is considered to be a potential factor of poor prognosis. Therefore, monitoring the expression of HER2 r…

meta-analysis 2022
Frontiers in oncology ·doi:10.3389/fonc.2022.840433

OBJECTIVE: The purpose of this meta-analysis was to provide evidence for using maximum uptake value (SUVmax) and apparent diffusion coefficient (ADC) to quantitatively differentiate benign and malignant ovarian or adnexal masses, and to ind…

meta-analysis 2021
BMC cancer ·doi:10.1186/s12885-021-08815-3

OBJECTIVE: To compare the value of fluorodeoxyglucose positron emission tomography (FDG-PET)/computed tomography (CT) and magnetic resonance imaging (MRI) in differentiating benign and malignant ovarian or adnexal tumors. MATERIALS AND MET…